{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:29:37Z","timestamp":1792373377177,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05750-2","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T07:03:17Z","timestamp":1729321397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Hao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihe","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinbiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"issue":"9935","key":"5750_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet"},{"issue":"1","key":"5750_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"5750_CR3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1634\/theoncologist.2017-0439","volume":"23","author":"CY Jing","year":"2018","unstructured":"Jing CY, Fu YP, Huang JL, et al. Prognostic nomogram based on histological characteristics of fibrotic tumor stroma in patients who underwent curative resection for intrahepatic cholangiocarcinoma. Oncologist. 2018;23(12):1482\u201393.","journal-title":"Oncologist"},{"issue":"23","key":"5750_CR4","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC de Jong","year":"2011","unstructured":"de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140\u20135.","journal-title":"J Clin Oncol"},{"issue":"11","key":"5750_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1477-2574.2012.00536.x","volume":"14","author":"CD Witjes","year":"2012","unstructured":"Witjes CD, Karim-Kos HE, Visser O, et al. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB. 2012;14(11):777\u201381.","journal-title":"HPB"},{"issue":"3","key":"5750_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/hep.29904","volume":"68","author":"Y Kurebayashi","year":"2018","unstructured":"Kurebayashi Y, Ojima H, Tsujikawa H, et al. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology. 2018;68(3):1025\u201341.","journal-title":"Hepatology"},{"issue":"3","key":"5750_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.trecan.2018.01.007","volume":"4","author":"D H\u00f8gdall","year":"2018","unstructured":"H\u00f8gdall D, Lewinska M, Andersen JB. Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma. Trends Cancer. 2018;4(3):239\u201355.","journal-title":"Trends Cancer"},{"issue":"6","key":"5750_CR8","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1002\/hep.26762","volume":"59","author":"AE Sirica","year":"2014","unstructured":"Sirica AE, Gores GJ. Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology. 2014;59(6):2397\u2013402.","journal-title":"Hepatology"},{"issue":"3","key":"5750_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","volume":"25","author":"MA Morse","year":"2019","unstructured":"Morse MA, Sun W, Kim R, et al. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res. 2019;25(3):912\u201320.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5750_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","volume":"18","author":"J Gracia-Sancho","year":"2021","unstructured":"Gracia-Sancho J, Caparr\u00f3s E, Fern\u00e1ndez-Iglesias A, et al. Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol. 2021;18(6):411\u201331.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5750_CR11","doi-asserted-by":"publisher","first-page":"691391","DOI":"10.3389\/fgene.2021.691391","volume":"12","author":"SL Huang","year":"2021","unstructured":"Huang SL, Wang YM, Wang QY, et al. Mechanisms and clinical trials of hepatocellular carcinoma immunotherapy. Front Genet. 2021;12:691391.","journal-title":"Front Genet"},{"key":"5750_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fonc.2019.00490","volume":"9","author":"I Heidegger","year":"2019","unstructured":"Heidegger I, Pircher A, Pichler R. Targeting the tumor microenvironment in renal cell cancer biology and therapy. Front Oncol. 2019;9:490.","journal-title":"Front Oncol"},{"issue":"10","key":"5750_CR13","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.3390\/ijms12107077","volume":"12","author":"A Pircher","year":"2011","unstructured":"Pircher A, Hilbe W, Heidegger I, et al. Biomarkers in tumor angiogenesis and anti-angiogenic therapy. Int J Mol Sci. 2011;12(10):7077\u201399.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"5750_CR14","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"4","key":"5750_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"AL Cheng","year":"2022","unstructured":"Cheng AL, Qin S, Ikeda M, et al. Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76(4):862\u201373.","journal-title":"J Hepatol"},{"issue":"7","key":"5750_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004892","volume":"10","author":"J Lin","year":"2022","unstructured":"Lin J, Dai Y, Sang C, et al. Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities. J Immunother Cancer. 2022;10(7): e004892.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5750_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 2022;40(1):70-87.e15.","journal-title":"Cancer Cell"},{"issue":"7693","key":"5750_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"2","key":"5750_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5750_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma. Nat Rev Dis Prim. 2021;7(1):65.","journal-title":"Nat Rev Dis Prim"},{"issue":"8","key":"5750_CR21","first-page":"1669","volume":"71","author":"RIR Macias","year":"2022","unstructured":"Macias RIR, Cardinale V, Kendall TJ, et al. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut. 2022;71(8):1669\u201383.","journal-title":"Gut"},{"issue":"25","key":"5750_CR22","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1038\/s41388-021-01844-z","volume":"40","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yu H, Xie X, et al. Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1\/CKAP4\/PI3K signaling pathway. Oncogene. 2021;40(25):4324\u201337.","journal-title":"Oncogene"},{"issue":"5","key":"5750_CR23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang H, Wan L, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol. 2020;73(5):1118\u201330.","journal-title":"J Hepatol"},{"issue":"8","key":"5750_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Mousa M, Nadukkandy AS, et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat Rev Cancer. 2023;23(8):544\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5750_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41418-019-0287-8","volume":"26","author":"MB Schaaf","year":"2019","unstructured":"Schaaf MB, Houbaert D, Me\u00e7e O, et al. Autophagy in endothelial cells and tumor angiogenesis. Cell Death Differ. 2019;26(4):665\u201379.","journal-title":"Cell Death Differ"},{"issue":"7","key":"5750_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41422-022-00650-w","volume":"32","author":"X Wang","year":"2022","unstructured":"Wang X, Chen Z, Xu J, et al. SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors. Cell Res. 2022;32(7):638\u201358.","journal-title":"Cell Res"},{"key":"5750_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.semcancer.2019.07.024","volume":"60","author":"F Orso","year":"2020","unstructured":"Orso F, Quirico L, Dettori D, et al. Role of miRNAs in tumor and endothelial cell interactions during tumor progression. Semin Cancer Biol. 2020;60:214\u201324.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"5750_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molmed.2023.11.002","volume":"30","author":"AH Cleveland","year":"2024","unstructured":"Cleveland AH, Fan Y. Reprogramming endothelial cells to empower cancer immunotherapy. Trends Mol Med. 2024;30(2):126\u201335.","journal-title":"Trends Mol Med"},{"issue":"16","key":"5750_CR29","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.7150\/thno.61881","volume":"11","author":"D Cabrerizo-Granados","year":"2021","unstructured":"Cabrerizo-Granados D, Pe\u00f1a R, Palacios L, et al. Snail1 expression in endothelial cells controls growth, angiogenesis and differentiation of breast tumors. Theranostics. 2021;11(16):7671\u201384.","journal-title":"Theranostics"},{"issue":"9","key":"5750_CR30","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","volume":"68","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Yang J, Xu D, et al. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019;68(9):1653\u201366.","journal-title":"Gut"},{"issue":"30","key":"5750_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202206","volume":"9","author":"C Zhong","year":"2022","unstructured":"Zhong C, Niu Y, Liu W, et al. S100A9 derived from chemoembolization-induced hypoxia governs mitochondrial function in hepatocellular carcinoma progression. Adv Sci. 2022;9(30): e2202206.","journal-title":"Adv Sci"},{"issue":"11","key":"5750_CR32","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","volume":"8","author":"D Denk","year":"2022","unstructured":"Denk D, Greten FR. Inflammation: the incubator of the tumor microenvironment. Trends Cancer. 2022;8(11):901\u201314.","journal-title":"Trends Cancer"},{"issue":"6","key":"5750_CR33","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1084\/jem.20181739","volume":"216","author":"B Ritter","year":"2019","unstructured":"Ritter B, Greten FR. Modulating inflammation for cancer therapy. J Exp Med. 2019;216(6):1234\u201343.","journal-title":"J Exp Med"},{"key":"5750_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2021.03.023","volume":"78","author":"SH Manjili","year":"2022","unstructured":"Manjili SH, Isbell M, Ghochaghi N, et al. Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse. Semin Cancer Biol. 2022;78:17\u201322.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"5750_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.trecan.2021.11.010","volume":"8","author":"M Kiely","year":"2022","unstructured":"Kiely M, Lord B, Ambs S. Immune response and inflammation in cancer health disparities. Trends Cancer. 2022;8(4):316\u201327.","journal-title":"Trends Cancer"},{"issue":"4","key":"5750_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179(4):829-45.e20.","journal-title":"Cell"},{"issue":"2","key":"5750_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrd3048","volume":"9","author":"RR Koenen","year":"2010","unstructured":"Koenen RR, Weber C. Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov. 2010;9(2):141\u201353.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"5750_CR38","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.immuni.2020.10.020","volume":"53","author":"E Bonavita","year":"2020","unstructured":"Bonavita E, Bromley CP, Jonsson G, et al. Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade. Immunity. 2020;53(6):1215-29.e8.","journal-title":"Immunity"},{"issue":"10","key":"5750_CR39","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander N, Zhang G, Lee JS, et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med. 2018;24(10):1545\u20139.","journal-title":"Nat Med"},{"issue":"3","key":"5750_CR40","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","volume":"168","author":"W Hugo","year":"2017","unstructured":"Hugo W, Zaretsky JM, Sun L, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2017;168(3):542.","journal-title":"Cell"},{"key":"5750_CR41","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1038\/ncomms10582","volume":"7","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Estrada MV, Salgado R, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy. Nat Commun. 2016;7:10582.","journal-title":"Nat Commun"},{"issue":"6","key":"5750_CR42","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77(6):1690\u20138.","journal-title":"J Hepatol"},{"issue":"1","key":"5750_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5750_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"5750_CR45","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio AA, Ferlay J, Znaor A, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666\u201378.","journal-title":"Cancer"},{"issue":"3","key":"5750_CR46","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729241","volume":"24","author":"YS Chun","year":"2017","unstructured":"Chun YS, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729241.","journal-title":"Cancer Control"},{"issue":"2","key":"5750_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;169(2):361\u201371.","journal-title":"Cell"},{"issue":"7677","key":"5750_CR48","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik S, Larsen SB, Gomez NC, et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550(7677):475\u201380.","journal-title":"Nature"},{"issue":"6371","key":"5750_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"5","key":"5750_CR50","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3390\/cancers12051150","volume":"12","author":"V de Gregorio","year":"2020","unstructured":"de Gregorio V, Urciuolo F, Netti PA, et al. In vitro organotypic systems to model tumor microenvironment in human papillomavirus (HPV)-related cancers. Cancers. 2020;12(5):1150.","journal-title":"Cancers"},{"key":"5750_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.canlet.2017.02.006","volume":"400","author":"K Hida","year":"2017","unstructured":"Hida K, Kikuchi H, Maishi N, et al. ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy. Cancer Lett. 2017;400:305\u201310.","journal-title":"Cancer Lett"},{"issue":"6","key":"5750_CR52","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-Gupta","year":"2012","unstructured":"Pylayeva-Gupta Y, Lee KE, Hajdu CH, et al. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell. 2012;21(6):836\u201347.","journal-title":"Cancer Cell"},{"issue":"10","key":"5750_CR53","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/liv.15366","volume":"42","author":"M Tanaka","year":"2022","unstructured":"Tanaka M, Kunita A, Yamagishi M, et al. KRAS mutation in intrahepatic cholangiocarcinoma: linkage with metastasis-free survival and reduced E-cadherin expression. Liver Int. 2022;42(10):2329\u201340.","journal-title":"Liver Int"},{"issue":"3","key":"5750_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, et al. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153\u20139.","journal-title":"Nat Rev Cancer"},{"key":"5750_CR55","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1038\/ncomms10292","volume":"7","author":"DD Sahtoe","year":"2016","unstructured":"Sahtoe DD, van Dijk WJ, Ekkebus R, et al. BAP1\/ASXL1 recruitment and activation for H2A deubiquitination. Nat Commun. 2016;7:10292.","journal-title":"Nat Commun"},{"issue":"6533","key":"5750_CR56","doi-asserted-by":"publisher","first-page":"eabc8697","DOI":"10.1126\/science.abc8697","volume":"371","author":"EH Hsiue","year":"2021","unstructured":"Hsiue EH, Wright KM, Douglass J, et al. Targeting a neoantigen derived from a common TP53 mutation. Science. 2021;371(6533):eabc8697.","journal-title":"Science"},{"issue":"6230","key":"5750_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348(6230):69\u201374.","journal-title":"Science"},{"issue":"1","key":"5750_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger I, Fotakis G, Offermann A, et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer. 2022;21(1):132.","journal-title":"Mol Cancer"},{"issue":"11","key":"5750_CR59","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li J, Lei W, et al. CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications. Int J Biol Sci. 2023;19(11):3341\u201359.","journal-title":"Int J Biol Sci"},{"key":"5750_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1476-4598-10-139","volume":"10","author":"B Uygur","year":"2011","unstructured":"Uygur B, Wu WS. SLUG promotes prostate cancer cell migration and invasion via CXCR4\/CXCL12 axis. Mol Cancer. 2011;10:139.","journal-title":"Mol Cancer"},{"key":"5750_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","volume":"65","author":"SK Daniel","year":"2020","unstructured":"Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol. 2020;65:176\u201388.","journal-title":"Semin Cancer Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05750-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05750-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05750-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T19:03:20Z","timestamp":1729364600000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05750-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5750"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05750-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval for this study was obtained from the Ethics Committee of Medical School of Chinese People's Liberation Army (PLA), approval number (S2018-111-01). All participants provided written informed consent before enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no conflicts to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"948"}}